Cranston D, Wood K J, Carter N, Morris P J
Transplantation. 1987 Jun;43(6):809-13.
The induction of antigen-induced immunosuppression by highly purified lymphocyte populations of different phenotypes was investigated in a rat renal allograft model (LEW-to-DA). Lymphocyte populations were prepared from Lewis spleen cells by rosette depletion and flow cytometric separation. Rosette depletion was performed using appropriate monoclonal reagents. B cells were prepared from spleen lymphocytes by rosette depletion of T cells, using three monoclonal antibodies: MRC OX19 (anti-T-cell), MRC OX8 (anti-T-cytotoxic/suppressor) and MRC W3/25 (anti-T-helper). T cells were purified by rosette depletion of B cells with MRC OX12 (anti-rat-K-chain). After depletion the lymphocyte populations were analyzed by flow cytometry and the purity of each preparation determined. B cells were 93.6% pure and T cells were 92.4% pure. Intravenous injection of 5 X 10(6) of these LEW B or T cells one week before transplantation of a LEW kidney into a DA recipient resulted in was indefinite renal allograft survival (median survival time [MST] greater than 100 days). Purification of the enriched B and T cell preparations by flow sorting resulted in highly purified populations of spleen B cells (99.3%) and T cells (98.2%). Further fractionation of the T cells into cells of T helper (99.6%) (i.e., W3/25-positive) and T cytotoxic/suppressor phenotype (99.4%) (i.e., MRC OX8-positive) was performed. While purified B cells, T cells, and T helper cells, given at a dose of 10(6) cells intravenously one week before transplantation resulted in long-term renal allograft survival (MST greater than 100 days), cells of the T cytotoxic/suppressor phenotype did not prevent graft rejection at this dose (MST 10 days).
在大鼠肾移植模型(从LEW到DA)中,研究了不同表型的高度纯化淋巴细胞群体诱导抗原诱导的免疫抑制作用。通过玫瑰花环去除法和流式细胞术分选从Lewis脾细胞中制备淋巴细胞群体。使用适当的单克隆试剂进行玫瑰花环去除。使用三种单克隆抗体:MRC OX19(抗T细胞)、MRC OX8(抗T细胞毒性/抑制细胞)和MRC W3/25(抗T辅助细胞),通过T细胞的玫瑰花环去除从脾淋巴细胞中制备B细胞。用MRC OX12(抗大鼠K链)通过B细胞的玫瑰花环去除纯化T细胞。去除后,通过流式细胞术分析淋巴细胞群体并确定每种制剂的纯度。B细胞纯度为93.6%,T细胞纯度为92.4%。在将LEW肾移植到DA受体前一周静脉注射5×10⁶个这些LEW B或T细胞,导致肾移植长期存活(中位存活时间[MST]大于100天)。通过流式分选对富集的B和T细胞制剂进行纯化,得到高度纯化的脾B细胞群体(99.3%)和T细胞群体(98.2%)。进一步将T细胞分为T辅助细胞(99.6%)(即W3/25阳性)和T细胞毒性/抑制细胞表型(99.4%)(即MRC OX8阳性)。虽然在移植前一周静脉注射剂量为10⁶个细胞的纯化B细胞、T细胞和T辅助细胞可导致肾移植长期存活(MST大于100天),但在此剂量下,T细胞毒性/抑制细胞表型的细胞不能防止移植排斥(MST为10天)。